Diagnostic Testing After Positive Cell‐Free DNA Screening for Sex Chromosome Aneuploidies: Clinical and Socioeconomic Determinants
Prenatal Diagnosis · 2026
DOI: 10.1002/pd.70229 ↗Kurz gefasst
Fachartikel in der Zeitschrift Prenatal Diagnosis, 2026. Verfasst von Blair K Stevens und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Texas Health Science Center at Houston, Houston, Texas, USA. Hauptthemen laut MEDLINE: Aneuploidy, Cell-Free Nucleic Acids, Prenatal Diagnosis, Sex Chromosome Aberrations. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
To assess socioeconomic and medical factors associated with prenatal confirmatory diagnostic testing after positive prenatal cell‐free (cfDNA) screening for sex chromosome aneuploidies (SCA) in a diverse contemporary patient cohort.
Methods
We conducted a retrospective cohort study of patients who had abnormal prenatal cfDNA screening results indicative of SCA and were seen for genetic counseling between 2014 and 2024 at two tertiary academic medical centers. We used logistic regression analysis to evaluate the association of demographic and clinical factors with confirmatory testing.
Results
Of the 692 patients with abnormal cfDNA results, 26% ( n = 180) underwent diagnostic testing. These patients were older, resided in more affluent areas, presented earlier for genetic counseling, were more likely to have commercial insurance, and were less likely to prefer Spanish or use an interpreter. Compared to Non‐Hispanic (NH) Whites, diagnostic testing rates were higher for NH Asians but were lower for NH Blacks and Hispanics or when results indicated XYY or XXX. In logistic modeling, lower deprivation scores and commercial insurance were independently associated with higher testing rates.
Conclusion
Only 1 in 4 patients pursued prenatal diagnostic testing following positive cfDNA screening for SCAs. Race, ethnicity, socioeconomic status and preferred language were the primary determinants of testing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Texas Health Science Center at Houston, Houston, Texas, USA.
- Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, Texas, USA.
- Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.
- John P and Kathrine G McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas, USA.
- Department of Biostatistics and Data Science, The University of Texas Health Science Center at Houston School of Public Health, Houston, Texas, USA.
- Department of Internal Medicine, The University of Texas Health Science Center at Houston, Houston, Texas, USA.
ORCID-Profile: Blair K Stevens, Sarah Araji, Mohamad Ali Maktabi, Randy Liu, Lauren Westerfield, Michael Wassef, Ignatia B Van den Veyver, Charlotte Lawrence, Siddharth K Prakash
Zitieren
APA
Stevens, B. K., Araji, S., Maktabi, M. A., Liu, R., Westerfield, L., Wassef, M., Lai, D., Van den Veyver, I. B., Krishnan, M., Lawrence, C., & Prakash, S. K. (2026). Diagnostic Testing After Positive Cell‐Free DNA Screening for Sex Chromosome Aneuploidies: Clinical and Socioeconomic Determinants. Prenatal Diagnosis. https://doi.org/10.1002/pd.70229
Vancouver
Stevens BK, Araji S, Maktabi MA, Liu R, Westerfield L, Wassef M, et al. Diagnostic Testing After Positive Cell‐Free DNA Screening for Sex Chromosome Aneuploidies: Clinical and Socioeconomic Determinants. Prenatal Diagnosis. 2026. doi:10.1002/pd.70229
BibTeX
@article{Stevens2026,
author = {Stevens, Blair K and Araji, Sarah and Maktabi, Mohamad Ali and Liu, Randy and Westerfield, Lauren and Wassef, Michael and Lai, Dejian and Van den Veyver, Ignatia B and Krishnan, Meera and Lawrence, Charlotte and Prakash, Siddharth K},
title = {Diagnostic Testing After Positive Cell‐Free DNA Screening for Sex Chromosome Aneuploidies: Clinical and Socioeconomic Determinants},
journal = {Prenatal Diagnosis},
year = {2026},
doi = {10.1002/pd.70229}
}
EUVIMED